SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Clinical trial NCT06516926 · TERMINATED
Trial details
- NCT number
- NCT06516926
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-08
- Primary completion
- 2025-05-23
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.